Dizal Pharmaceuticals
Clinical trials sponsored by Dizal Pharmaceuticals, explained in plain language.
-
New pill could outperform chemo for rare lung cancer
Disease control OngoingThis phase 3 trial tests a new oral drug called sunvozertinib (DZD9008) against standard chemotherapy in 324 people with advanced non-small cell lung cancer that has a specific EGFR mutation (exon20 insertion). Participants are randomly assigned to receive either the new drug or …
Phase: PHASE3 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New hope for Hard-to-Treat lymphoma: experimental drug DZD8586 enters phase 2 trial
Disease control OngoingThis phase 2 trial tests an experimental drug called DZD8586 in 59 adults with diffuse large B-cell lymphoma that has come back or not responded to previous treatment. The study aims to see if the drug can shrink tumors and to understand its side effects and how the body processe…
Phase: PHASE2 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
New pill shows promise against tough lung cancer
Disease control OngoingThis study tests a new daily pill, sunvozertinib (DZD9008), in people with advanced non-small cell lung cancer that has certain genetic mutations (EGFR or HER2) and has worsened after prior treatments. The trial aims to find safe doses and see if the drug can shrink tumors. About…
Phase: PHASE1, PHASE2 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC